Tyra Biosciences, Inc.

TYRA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$86-$69-$55-$26
Dep. & Amort.$1$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$23$0$0$3
Change in WC-$1$6-$6-$0
Other Non-Cash-$6$12$11$0
Operating Cash Flow-$70-$50-$50-$24
Investing Activities
PP&E Inv.-$1-$1-$1-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$264-$144$0$0
Inv. Sales/Matur.$166$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$98-$145-$1-$1
Financing Activities
Debt Repay.$0$0$0-$0
Stock Issued$200$2$1$181
Stock Repurch.-$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$3$0$0$130
Financing Cash Flow$202$2$1$311
Forex Effect$0$0-$1$0
Net Chg. in Cash$34-$193-$51$287
Supplemental Information
Beg. Cash$59$251$302$15
End Cash$93$58$251$302
Free Cash Flow-$70-$51-$51-$24